health - "cancer"

Randy Pausch, the computer science professor who rose to fame after giving a quirky last lecture about celebrating life in the face of his terminal cancer, died Friday.

Nexavar drug is found to improve survival rates in liver cancer patients.A joint team of researchers from Hospital Clinic of Barcelona and Barcelona Clinic Liver cancer (BCLC) Group has examined 602 advanced liver cancer patients who were divided into two groups: one group was taking Nexavar - sorafenib, the second group was taking a placebo.read more

Will scientist's warning about a cancer-cell phone link change buyers' minds?

This year's survey by the Hawai'i State Department of Health's Alcohol and Drug Abuse Division (ADAD) shows that illegal sales of tobacco to minors in Hawai'i has increased from 8.7 percent in 2007 to 11.2 percent in 2008. At the current rate, Hawai'i is above the national average of 10.5 percent. The 13th annual survey was conducted by a joint program with the University of Hawai'i's cancer Research Center of Hawai'i and ADAD. The program conducts inspections of retail outlets that sell tobacco to determine the extent of illegal sales of tobacco products to minors.read more

WOMEN newly diagnosed with breast cancer could be faced with the extra dilemma of having to decide whether to be tested for dangerous gene mutations, as evidence emerges that those with high-risk changes to the ...

Genetic testing for BRCA1 and BRCA2 (BRCA1/2) mutations can provide important information for women who are concerned about their breast and ovarian cancer risks and need to make relevant prevention and medical management decisions. However, lifetime risks of breast cancer in individual BRCA1/2 mutation carriers have been confusing to apply in clinical decision-making. Published risk estimates vary significantly and are very dependent on the characteristics of the population under study. Recently, Begg et al. estimated cancer risks in a population-based study of BRCA1/2 mutation carriers. Here, we discuss the clinical decision-making implications of this research in the context of risk factors that may influence risk estimates in BRCA1/2 mutation carriers.

The physician who launched a breast cancer testing program in St. John's more than a decade ago told an inquiry that pathology was treated dismally during that era.

One of the first things people do when they are diagnosed with cancer is go online and look up their disease. The Internet has become a patient's best friend -- for better or worse.

A study that links Vytorin to cancer has provoked controversy among heart specialists worried that the drug's risks may outweigh ...

Damage can be measured by newly captured events in cell's powerhouse Researchers have taken a first snapshot of how a class of highly reactive molecules inflicts cellular damage as part of aging, heart disease, stroke, cancer, diabetes, kidney disease and Alzheimer's disease to name a few.